IL10 and inflammatory bowel disease: To determine if ALDH1A inhibition suppresses colitis in another mouse model of IBD with a different mechanism of disease development, we tested the efficacy of WIN 18,446 in Il10−/− mice using the same study design as Mdr1a−/− mice.